Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
Industry-sponsored satellite symposia at the 23rd EURETINA Congress
Attendees can take advantage of many satellite symposia sponsored by industry. Experts from around the world will present during the symposia.
23rd annual EURETINA Congress: seeing eye to eye in Amsterdam
Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops.
Combined use of e-cigarettes and cigarettes causes severe and frequent ocular symptoms in adolescents and young adults
When smokers used both cigarettes and e-cigarettes, studies showed additional detrimental findings, such as lower general health, increased sleep latency, and higher vascular disorder risk.
RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital
The AI retinal scanning model will be free to use for all institutions.
COVID-19 treatment changes infant’s eye color
The 6-month-old boy’s dark brown eyes turned deep blue after he was treated for COVID with favipiravir.
WIO 2023: New developments in vitreoretinal surgery 3D viewing systems and robotics: The future Is now
The 3D viewing systems and digital microscopes offer numerous advantages for performing the procedures.
Immunosuppressants used to control ocular inflammation not involved in cancer development
Commonly used immunosuppressants used in the short term to control an ocular inflammatory disease were not associated with increased risk of developing cancer later.
Certain inherited retinal diseases are characterized by large cystoid macular lesions
Optical coherence tomography analysis of measurements of cystoid macular lesions showed that patients with different IRD phenotypes can develop very large CMLs.
Retina biomarkers identified 7 years before clinical diagnosis of Parkinson's disease
Researchers have identified markers that indicate the presence of Parkinson’s disease in patients an average of 7 years before the disease presents clinically.
AI-generated ophthalmic references and abstracts: Proceed with caution
Clinicians should be alert to the fact that while artificial intelligence (AI) is capable of generating ideas and references, it is crucial to thoroughly vet and fact-check any medical research content that AI produces.
Macular retinal detachment development associated with myopic foveoschisis
Without treatment, severe visual impairment can occur; the first-line treatment for these cases is anti-vascular endothelial growth factor therapy (VEGF).
Research shows early vitrectomy using silicone oil tamponade for endophthalmitis improves vision
In this study, the investigators retrospectively reviewed all study patients who underwent pars plana vitrectomy with silicone oil tamponade for postsurgical endophthalmitis.
Want to know about retinal and choroidal vascular parameters in patients with CSC? Look to their nails
An experienced dermatologist blinded to clinical data performed the NVC using a videocapillaroscope VideoCap 3.0 (DSMedica) at 200× magnification in the study.
Gene therapy company, Intergalactic Therapeutics announces closing
Intergalactic Therapeutics, based in Cambridge, MA, announced its closing after less than 2 years since the company's launch in 2021.
Factors Affecting the Age of Onset of age-related macular edema (AMD)
The investigators explored the effects of the following covariates on development of AMD: sex, ethnicity, smoking history, fluoxetine use, obesity, diabetes mellitus, and hypertension.
Women in Ophthalmology (WIO) coming to Marco Island, Florida
In addition to the educational offerings, the program offers opportunities for relaxation and spiritual and family-building events.
Ophthalmic World Leaders (OWL) Leadership Summit to host meeting to promote and develop diverse leadership
The Summit will inspire and enable attendees to achieve their goals via a multi-pronged approach.
Study determines female ophthalmology students were less likely to ask questions during grand rounds
The main finding was that the male grand round attendees were more likely to pose 1 of the first 3 questions compared with female attendees.
ASRS 2023: GALE extension study showed increasing beneficial effects for SYFOVRE (pegcetacoplan injection) over 30 months
Apellis Pharmaceuticals, Inc. presented results from the GALE extension study at the 2023 ASRS annual meeting in Seattle. The results indicated that continuous treatment with SYFOVRE (pegcetacoplan injection) for 30 months continued to show increasing beneficial effects.
ASRS 2023: Intended versus actual treatment intervals between Intravitreal anti-VEGF Injections: Effects of treatment delays
In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.
ASRS 2023: Not all full-thickness macular holes require surgery; blunt ocular trauma and hole size may merit observation
The research saw that new-onset full-thickness macular holes (FTMHs), especially those resulting from blunt ocular trauma, might close spontaneously without the need for a surgical intervention.
ASRS 2023: Efficacy/safety of biosimilars ranibizumab-nuna and ranibizumab-eqrn in clinical use
This study of patients was designed to identify unexpected adverse effects of these new pharmacologic therapies that may not have been observed or anticipated during clinical research trials. The studied drugs were biosimilars to the reference drug ranibizumab.
ASRS 2023: AAVIATE Interim Safety Study: 6-Month Results Underscore Treatment Safety with Suprachoroidally Injected ABBV-RGX-314 for nAMD
RGX-314, an investigational formulation being developed in collaboration with AbbVie, may be a potential one-time treatment for nAMD, diabetic retinopathy, and other chronic retinal conditions.
ASRS 2023: Normalized blood flow index provides biomarker for diabetic retinopathy detection
Lim and colleagues conducted a retrospective study to establish the normalized NBFI using OCTA and test if that index is sufficiently sensitive for detecting early DR.
ASRS 2023: Long-term cognitive outcomes not negatively impacted by intravitreal bevacizumab for ROP
Detrimental effects of IVB may not be recognized at an early age, which underscores the importance of following these children over time.
Applying deep learning to retinitis pigmentosa patients to estimate visual acuity
Using automated methods to determine the visual acuity showed robust performance in predicting visual impairment.
Ocular posterior segment complications of the COVID-19 vaccination
While these complications are rare, they require prompt diagnosis and management to prevent serious visual morbidity.
ASRS 2023: Getting a Bird’s Eye View of the Seattle Scene
The 2023 41st annual meeting of the American Society of Retina Specialists (ASRS) will run from Thursday, July 27 to Tuesday, August 1 in Seattle, a city filled with sightseeing, museums, and great food to explore.
Screening for diabetic retinopathy: 1 image says it all
Investigators set out to evaluate how well an AI system works when integrated into a handheld smartphone-based retinal camera to screen patients for DR using 1 retinal image in each eye.
ASRS 2023: Premier meeting for retina science and innovation
ASRS is an international, state-or-the-art event offering something for everyone: scientific papers, posters, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses.
2 Clarke Drive Cranbury, NJ 08512